Q3 2013
Released Nov 14, 2013, after the close
10-Q filed Nov 14, 2013, 45 days after period end · 0001144204-13-061818
Q3 2013 · 10-Q
Revenue$418.00K$418.00K −30.8% vs Q3 2012−27.3% vs Q2 2013
Net Income-$2.41M-$2.41M N/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$0.14-$0.14 N/M vs Q3 2012N/M vs Q2 2013
Gross Profit$229,000−44.6%
Operating Income-$608,000N/M
Operating Cash Flowderived-$138,000N/M
Margins · derived
Gross margin54.8%−13.6 pt vs Q3 2012
Operating margin-145.5%−4.2 pt vs Q3 2012
Net margin-576.1%−434.9 pt vs Q3 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $418.00K | $604.00K | $407.00K | $622.00K |
| Net Income | -$2.41M | -$853.00K | -$413.00K | -$375.00K |
| EPS Diluted | -$0.14 | -$0.07 | -$0.04 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR